Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-645-0825
Fax+1 601-984-5503
Dr. Willis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Neuroimmunology & Multiple Sclerosis, 2011 - 2012
University of Mississippi Medical CenterChief Residency, Neurology, 2010 - 2011- University of Mississippi Medical CenterResidency, Neurology, 2007 - 2011
- University of Mississippi Medical CenterInternship, Internal Medicine, 2007 - 2008
- University of Mississippi School of MedicineClass of 2007
Certifications & Licensure
MS State Medical License 2009 - 2026
OH State Medical License 2013 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2016-2017
- CMS Meaningful Use Stage 1 Certification PrimeSuite, Greenway Health, LLC, 2013, 2016-2017
Clinical Trials
- Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. Start of enrollment: 2015 Feb 28
- Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS Start of enrollment: 2019 Jan 03
Publications & Presentations
PubMed
- Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Mary Alissa Willis
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2025-12-09 - 1 citationsSatralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy Nealon
Journal of Neuroimmunology. 2025-06-15 - 9 citationsDisparities in spatial access to neurological care in Appalachia: a cross-sectional health services analysis.R Blake Buchalter, Erik G Gentry, Mary A Willis, Marisa P McGinley
Lancet Regional Health. Americas. 2023-02-01
Journal Articles
- Cerebral infarction from AIDS-related Cryptococcal MeningitisBurton MJ, Willis MA, Geraci SA, Chapman SW, Pappas PG, Infect Dis Clin Pract, 5/2010
Books/Book Chapters
Press Mentions
How Multiple Sclerosis Affects Your BodyNovember 27th, 2022- Comparing Health Promotion and Quality of Life in People with Progressive Versus Nonprogressive Multiple SclerosisOctober 27th, 2020
Why Virtual Visits, IBM’s Watson and Other Telemedicine Advances Keep One Neurologist Excited About the FutureMarch 22nd, 2018
Committees
- Member, Editorial Board, International Journal of MS Care 2012 - Present
- Chair, Outcomes and Quality Committee of the Mellen Center for MS, Cleveland Clinic 2014 - 2019
- Director, Board of Directors, Multiple Sclerosis Association of America 2013 - 2017
Professional Memberships
- Member
- Member
- Fellow
- American Neurological AssociationFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
